On October 30, Cognition presented a pre-specified analysis of data from the Phase 2 SHINE study (NCT03507790) of CT1812 in participants with mild-to-moderate Alzheimer’s disease at the Clinical Trials on Alzheimer’s Disease (CTAD) conference.
The live event has concluded.
Please visit https://viavid.webcasts.com/starthere.jsp?ei=1694880&tp_key=f312676b26 for an archive of the webcast and presentation.
Download the presentation (PDF)
Cognition Therapeutics
info@cogrx.com
Mikey Moyer
LifeSci Advisors
mmoyer@lifesciadvisors.com
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.
